FTL Capital
FTL Capital is a Missouri-based private equity firm founded in 2001. The firm specializes in investing in companies across various industries, including technology, media, telecommunications, business services, and financial services, primarily within the United States. FTL Capital targets firms with revenues up to $100 million and EBITDA up to $5 million, with a preference for entrepreneur or family-owned businesses. The firm typically seeks to acquire a controlling interest or significant influence in its investments, focusing on management turnarounds, spin-outs, and restructuring opportunities, particularly in special and distressed ownership situations.
As of January 8, 2019, Pulse Therapeutics, Inc. was acquired by Ichor Vascular, Inc. Pulse Therapeutics, Inc., a medical technology company, develops magnetically-enhanced diffusion (MED) system for the treatment of stroke, heart, and other diseases. Its MED system is used to harness magnet-based technology to dissolve blood clots faster than current modalities. The company also provides MED MicroBeads that are designed to convey physician-selected agents faster to the blood clot; intravenously administered after thrombolysis therapy is initiated; and mechanical adjunct to standard of care IV thrombolysis. In addition, it offers touch screen operated MED Workstation. Pulse Therapeutics, Inc. was incorporated in 2008 and is based in St. Louis, Missouri.
myEDmatch, LLC operates a matchmaking employment Website for educators and schools with shared missions, beliefs, and goals to find each other in the United States. Its Website helps teachers to match them with the right job in a good-fit school; and school leaders to fill their open teaching jobs. The company was incorporated in 2012 and is based in Kansas City, Missouri. As of February 4, 2016, myEDmatch, LLC operates as a subsidiary of Teachers-Teachers.com, Inc.
As of January 8, 2019, Pulse Therapeutics, Inc. was acquired by Ichor Vascular, Inc. Pulse Therapeutics, Inc., a medical technology company, develops magnetically-enhanced diffusion (MED) system for the treatment of stroke, heart, and other diseases. Its MED system is used to harness magnet-based technology to dissolve blood clots faster than current modalities. The company also provides MED MicroBeads that are designed to convey physician-selected agents faster to the blood clot; intravenously administered after thrombolysis therapy is initiated; and mechanical adjunct to standard of care IV thrombolysis. In addition, it offers touch screen operated MED Workstation. Pulse Therapeutics, Inc. was incorporated in 2008 and is based in St. Louis, Missouri.